Table 2 Overlap weighted demographic and clinical characteristics of 203 lung transplant recipients
Overall (n = 203) | Male (n = 122) | Female (n = 81) | |
|---|---|---|---|
Preoperative characteristics | |||
Age, y | 54 | 54 | 54 |
BMI, kg/m2 | 25 | 25 | 25 |
Primary disease | |||
Cystic fibrosis or COPD | 88 (44) | 53 (44) | 35 (44) |
Restrictive lung disease or pulmonary vascular disease | 115 (56) | 69 (56) | 46 (56) |
Lung allocation score | 44 | 44 | 44 |
Condition at time of transplant | |||
Hospitalized or in ICU | 27 (13) | 16 (13) | 11 (13) |
Not hospitalized | 176 (87) | 106 (87) | 70 (87) |
Life support before transplanta | 18 (9) | 11 (9) | 7 (9.) |
Pulmonary hypertensionb | 157 (77) | 94 (77) | 63 (77) |
Preoperative immunosuppression agents | 93 (46) | 56 (46) | 37 (46) |
Prior surgery | 48 (24) | 29 (24) | 19 (24) |
Donor characteristics | |||
Age, y | 35 | 35 | 35 |
Extended criteria donorc | 85 (42) | 51 (42) | 34 (42) |
Ever smoked | 97 (48) | 58 (48) | 39 (48) |
Donor sex | |||
Male | 82 (40) | 49 (40) | 33 (40) |
Female | 122 (60) | 73 (60) | 49 (60) |
Donation after circulatory death | 13 (6) | 8 (6) | 5 (6) |
Ex vivo lung perfusion | 25 (13) | 15 (13) | 10 (13) |
Operative details | |||
Type of transplant | |||
Single | 162 (80) | 97 (80) | 65 (80) |
Bilateral | 41 (20) | 25 (20) | 16 (20) |
Type of intraoperative supportd | 0.9 | 0.9 | 0.9 |
Total ischemic time, min | 330 | 330 | 330 |